These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 28971860)
1. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice. Panic G; Ruf MT; Keiser J Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860 [TBL] [Abstract][Full Text] [Related]
2. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured]. Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311 [TBL] [Abstract][Full Text] [Related]
3. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments. Coelho PM; Lima e Silva FC; Nogueira-Machado JA Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523 [TBL] [Abstract][Full Text] [Related]
4. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy. Fallon PG; Fookes RE; Wharton GA Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801 [TBL] [Abstract][Full Text] [Related]
5. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni. Araujo N; Mattos AC; Coelho PM; Katz N Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417 [TBL] [Abstract][Full Text] [Related]
6. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel. Bonesso-Sabadini PI; de Souza Dias LC Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody. Fallon PG; Hamilton JV; Doenhoff MJ Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991 [TBL] [Abstract][Full Text] [Related]
8. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection. Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933 [TBL] [Abstract][Full Text] [Related]
9. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni. Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757 [TBL] [Abstract][Full Text] [Related]
10. Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal. Keiser J; Panic G; Vargas M; Wang C; Dong Y; Gautam N; Vennerstrom JL J Antimicrob Chemother; 2015; 70(6):1788-97. PubMed ID: 25691324 [TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238 [TBL] [Abstract][Full Text] [Related]
12. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy. Buchter V; Hess J; Gasser G; Keiser J Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice. Silva LM; Menezes RM; de Oliveira SA; Andrade ZA Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033 [TBL] [Abstract][Full Text] [Related]
14. Relationship between schistosomicidal drug efficacy, gonadal steroid hormonal changes and state of disease immunopathology in murine schistosomiasis mansoni. Botros SS; Salama SH; Estafan MY; Gomaa NE; Metwally AA; Ebeid FA Pharmacol Res; 1990; 22(3):359-70. PubMed ID: 2114615 [TBL] [Abstract][Full Text] [Related]
15. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. Keiser J; Manneck T; Vargas M J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552 [TBL] [Abstract][Full Text] [Related]
16. A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing. Frahm S; Anisuzzaman A; Prodjinotho UF; Vejzagić N; Verschoor A; Prazeres da Costa C PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006590. PubMed ID: 30689639 [TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni: chemotherapy of infections of different ages. Sabah AA; Fletcher C; Webbe G; Doenhoff MJ Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment. Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880 [TBL] [Abstract][Full Text] [Related]
19. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Fallon PG; Doenhoff MJ Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919 [TBL] [Abstract][Full Text] [Related]
20. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents. Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]